Fatal and Non-fatal Overdose After Narcology Hospital Discharge Among Russians Living with HIV/AIDS Who Inject Drugs

Overview

Journal Int J Drug Policy

Publisher Elsevier

Specialties Psychiatry
Public Health

Date 2016 Dec 2

PMID 27907848

Citations 6

Authors

Alexander Y Walley

Debbie M Cheng

Emily K Quinn

Elena Blokhina

Natalia Gnatienko

Christine E Chaisson

Evgeny Krupitsky

Philip O Coffin

Jeffrey H Samet

Affiliations

Soon will be listed here.

Abstract

Objectives: Among Russians living with HIV/AIDS who inject drugs, we examined the incidence of fatal and non-fatal overdoses following discharge from a narcology hospital and the associations with more advanced HIV infection.

Design: Prospective cohort study of data collected at baseline, 3 and 6 months from HIV-infected patients with a history of injection drug use who were not treated with anti-retroviral therapy. Participants were recruited between 2012-2014 from a narcology (addiction) hospital in St. Petersburg, Russia.

Methods: Fatal overdose was determined based on contact reports to study staff in the year after discharge. Non-fatal overdose was self-reported at the 3- and 6-month assessments. The main independent variable for HIV severity was CD4 cell count at the baseline interview (<200cells/mm≥200cells/mm). Secondary analyses assessed time since HIV diagnosis and treated with anti-retroviral treatment (ART) prior to enrolment as independent variables. We fit Cox proportional hazards models to assess whether HIV severity is associated with either fatal or non-fatal overdose.

Results: Among 349 narcology patients, 18 participants died from overdose within one year after discharge (8.7%, 95% CI 3.4-14.2 by Kaplan-Meier); an estimated 51% [95% CI 34-68%] reported at least one non-fatal overdose within 6 months of discharge. HIV severity, time since HIV diagnosis and ever ART were not significantly associated with either fatal or non-fatal overdose events.

Conclusion: Fatal and non-fatal overdose are common among Russians living with HIV/AIDS who inject drugs after narcology hospital discharge. Overdose prevention interventions are urgently warranted among Russian narcology patients with HIV infection.

Citing Articles

Opioid overdose and inpatient care for substance use disorder care in Massachusetts.

Morgan J, Wang J, Barocas J, Jaeger J, Durham N, Babakhanlou-Chase H J Subst Abuse Treat. 2020; 112:42-48.

PMID: 32199545 PMC: 7928069. DOI: 10.1016/j.jsat.2020.01.017.

Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.

Walley A, Lodi S, Li Y, Bernson D, Babakhanlou-Chase H, Land T Addiction. 2020; 115(8):1496-1508.

PMID: 32096908 PMC: 7854020. DOI: 10.1111/add.14964.

A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care.

Samet J, Blokhina E, Cheng D, Walley A, Lioznov D, Gnatienko N AIDS. 2019; 33(9):1467-1476.

PMID: 30964750 PMC: 6635053. DOI: 10.1097/QAD.0000000000002230.

Homelessness and incarceration associated with relapse into stimulant and opioid use among youth who are street-involved in Vancouver, Canada.

Goldman-Hasbun J, Nosova E, Kerr T, Wood E, DeBeck K Drug Alcohol Rev. 2019; 38(4):428-434.

PMID: 30896070 PMC: 6508978. DOI: 10.1111/dar.12921.

Recognition of, and attitudes towards, people with depression and psychosis with/without alcohol and other drug problems: results from a national survey of Australian paramedics.

McCann T, Savic M, Ferguson N, Cheetham A, Witt K, Emond K BMJ Open. 2018; 8(12):e023860.

PMID: 30514822 PMC: 6286471. DOI: 10.1136/bmjopen-2018-023860.

References

Davoli M, Bargagli A, Perucci C, Schifano P, Belleudi V, Hickman M . Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007; 102(12):1954-9. DOI: 10.1111/j.1360-0443.2007.02025.x. View

Holt E . Russian injected drug use soars in face of political inertia. Lancet. 2010; 376(9734):13-4. DOI: 10.1016/s0140-6736(10)61041-0. View

Degenhardt L, Mathers B, Wirtz A, Wolfe D, Kamarulzaman A, Carrieri M . What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. Int J Drug Policy. 2013; 25(1):53-60. DOI: 10.1016/j.drugpo.2013.08.004. View

Hickman M, Carnwath Z, Madden P, Farrell M, Rooney C, Ashcroft R . Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. J Urban Health. 2003; 80(2):274-87. PMC: 3456282. DOI: 10.1093/jurban/jtg030. View

Coffin P, Sullivan S . Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013; 158(1):1-9. DOI: 10.7326/0003-4819-158-1-201301010-00003. View

Escudero D, Marshall B, Kerr T, Hayashi K, Feng C, Guillemi S . No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada. Addict Behav. 2016; 60:8-12. PMC: 4884456. DOI: 10.1016/j.addbeh.2016.03.029. View

Fischer B, Brissette S, Brochu S, Bruneau J, El-Guebaly N, Noel L . Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ. 2004; 171(3):235-9. PMC: 490072. DOI: 10.1503/cmaj.1031416. View

Chishinga N, Kinyanda E, Weiss H, Patel V, Ayles H, Seedat S . Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry. 2011; 11:75. PMC: 3112078. DOI: 10.1186/1471-244X-11-75. View

Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M . Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2010; 106(1):32-51. DOI: 10.1111/j.1360-0443.2010.03140.x. View

10.

Green T, McGowan S, Yokell M, Pouget E, Rich J . HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS. 2011; 26(4):403-17. PMC: 3329893. DOI: 10.1097/QAD.0b013e32834f19b6. View

11.

Brugal M, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L . Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005; 100(7):981-9. DOI: 10.1111/j.1360-0443.2005.01089.x. View

12.

Nosyk B, Min J, Evans E, Li L, Liu L, Lima V . The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clin Infect Dis. 2015; 61(7):1157-65. PMC: 4560909. DOI: 10.1093/cid/civ476. View

13.

Green T, Grau L, Blinnikova K, Torban M, Krupitsky E, Ilyuk R . Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. Int J Drug Policy. 2008; 20(3):270-6. PMC: 2696401. DOI: 10.1016/j.drugpo.2008.07.002. View

14.

Sergeev B, Karpets A, Sarang A, Tikhonov M . Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health. 2003; 80(2):212-9. PMC: 3456284. DOI: 10.1093/jurban/jtg024. View

15.

Fedorova E, Skochilov R, Heimer R, Case P, Beletsky L, Grau L . Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. BMC Public Health. 2013; 13:183. PMC: 3616994. DOI: 10.1186/1471-2458-13-183. View

16.

Wolfe D . Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy. 2007; 18(4):246-54. DOI: 10.1016/j.drugpo.2007.01.012. View

17.

Mathers B, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick R . HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375(9719):1014-28. DOI: 10.1016/S0140-6736(10)60232-2. View

18.

Stoove M, Dietze P, Jolley D . Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev. 2009; 28(4):347-52. DOI: 10.1111/j.1465-3362.2009.00057.x. View

19.

Mathers B, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M . Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013; 91(2):102-23. PMC: 3605003. DOI: 10.2471/BLT.12.108282. View

20.

Bird S, McAuley A, Perry S, Hunter C . Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction. 2015; 111(5):883-91. PMC: 4982071. DOI: 10.1111/add.13265. View